Abbott Laboratories



$54.64Share Price
$95.8 BMarket Cap
2.0%EBIT / EV
2.9%FCF / EV
6.0%Cash ROIC
-1.5%3yr Avg Revenue Growth
2.94Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark The EBIT / Enterprise Value of 2.0% ranks as Poor.
x mark The Free Cash Flow / Enterprise Value of 2.9% ranks as Below Average.
x mark The Return on Invested Capital Value of 4.1% ranks as Poor.
x mark The Cash Return on Capital Value of 6.0% ranks as Below Average.
x mark The 3 Year Average Revenue Growth Value of -1.5% ranks as Below Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 2.94.

Company Description

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.